ARIPRA aripiprazole 10 mg tablet blister pack

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

aripiprazole, Quantity: 10 mg

Mevcut itibaren:

Medis Pharma Pty Ltd

INN (International Adı):

aripiprazole

Farmasötik formu:

Tablet, uncoated

Kompozisyon:

Excipient Ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; maize starch; hyprolose

Uygulama yolu:

Oral

Paketteki üniteler:

30

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,Acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults as monotherapy and in combination with lithium or valproate;,Maintenance treatment of manic or mixed episodes in Bipolar I Disorder in adults as monotherapy.

Ürün özeti:

Visual Identification: 8mm x 5 mm, capsule shaped, biconvex, white uncoated tablets with 10 debossed on one side and ZL on the other side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Yetkilendirme durumu:

Licence status A

Yetkilendirme tarihi:

2014-10-29